Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Flurchem Flurbiprofen Sodium Ophthalmic Solution IP
Flurchem is an ophthalmic solution containing Flurbiprofen Sodium, a potent NSAID that works by reducing inflammation and alleviating pain in the eyes. This solution is designed to address symptoms associated with eye conditions and surgical procedures, providing effective relief.
Uses of Flurchem Flurbiprofen Sodium Ophthalmic Solution IP
Preoperative and Postoperative Inflammation: Used to manage inflammation and pain associated with ocular surgeries, including cataract surgery.
Eye Infections: Provides relief from inflammation related to bacterial, viral, or fungal infections of the eye.
Allergic Conjunctivitis: Alleviates symptoms of inflammation and discomfort caused by allergic reactions in the eye.
Uveitis: Treats inflammation of the uvea, the middle layer of the eye, to reduce symptoms and improve comfort.
Benefits of Flurchem Flurbiprofen Sodium Ophthalmic Solution IP
Effective Anti-Inflammatory Action: Flurbiprofen Sodium effectively reduces inflammation, providing significant relief from pain and discomfort in the eye.
Rapid Relief: Provides quick alleviation of symptoms related to ocular conditions and surgeries.
Reduced Need for Steroids: Offers an alternative to steroid-based treatments, minimizing potential side effects associated with corticosteroids.
Convenient Dosage Form: Comes in a 5 ml ophthalmic solution, allowing for precise application and easy administration.
Improved Patient Comfort: Helps in reducing postoperative discomfort and inflammation, enhancing patient recovery and comfort.
Mechanism of Action of Flurchem Flurbiprofen Sodium Ophthalmic Solution IP
Flurbiprofen Sodium: Flurbiprofen Sodium inhibits the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandinschemicals that mediate inflammation, pain, and fever. By blocking COX, Flurbiprofen Sodium reduces the synthesis of these inflammatory mediators, leading to decreased inflammation and pain in the eye.